Kura Oncology (KURA) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to a loss of $0.66 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of +5.33%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.72 per share when it actually produced a loss of $0.92, delivering a surprise of -27.78%. Over the last four quarters, th ...